Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3275 participants.

Also called NCT03814187

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 3,275 participants (enrolled count) (from the registry)
Sponsor
  • Novartis Registry lists this organization as the lead sponsor
Registry
  • NCT NCT03814187
  • EudraCT 2017-003092-55
Other papers using this trial's data
  • Inclisiran administration potently and durably lowers LDL-C over an extended-term follow-up: the ORION-8 trial Cardiovascular research, 2024-10-14 DOI, PubMed 38753448, PMC11481169 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada, Czechia, Denmark, Germany, Hungary, Netherlands, Poland, South Africa, Spain, Sweden, Ukraine, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03814187. Allocation not applicable; no masking; primary purpose treatment. Start 2019-04-16 (actual); primary completion 2023-02-13 (actual). Results posted on 2024-03-06.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C
Acronym
ORION-8
Condition
ASCVD
Condition
Elevated Cholesterol
Condition
Heterozygous Familial Hypercholesterolemia
Condition
Homozygous Familial Hypercholesterolemia
Intervention (Drug)
Inclisiran Sodium
Lead sponsor
Novartis Pharmaceuticals (class: industry)

Record details

Record id
cardio:ct-nct03814187
Content hash
4be60d494dc347868d1d617d1fd2d03bd6096d4fc648e364ba6b66936ad5cedb